About Biobot Analytics
Biobot Analytics is a private company based in Cambridge, Massachusetts. It has reported $41,024,536 raised in three offerings on Form D since April 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 23, 2025 | Jun 6, 2025 | $13,451,355of $13.5M target | 46 | $292K | Equity, OptionsRule 506(b) | Form D ↗ |
| Jul 23, 2021 | Aug 6, 2021amended Nov 17, 2021 | $20,833,737fully sold | 26 | $801K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 3, 2020 | Apr 17, 2020 | $6,739,444fully sold | 29 | $232K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $41,024,536 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Biobot Analytics's Form D filed Jun 6, 2025.
VP
Vivek Pattipati
Director
NG
Newsha Ghaeli
Executive officer and director
AP
Andrew Perlman
Director
MG
Mariana Matus Garcia
Executive officer and director
Earlier filings also listed Rich-Henry Schabowsky (director, last listed Nov 2021) and Ann DeWitt (director, last listed Nov 2021).